A Randomized, Open, Parallel-group, Multi-national, Multi-centre, Phase IV Study to Evaluate the Efficacy of Three Different Patient Management Strategies With and Without Esomeprazole 20 mg During a 3 Months Maintenance Phase Following an Initial 4-weeks Acute Treatment Phase in Subjects With Symptoms Thought to be GERD Related.

Trial Profile

A Randomized, Open, Parallel-group, Multi-national, Multi-centre, Phase IV Study to Evaluate the Efficacy of Three Different Patient Management Strategies With and Without Esomeprazole 20 mg During a 3 Months Maintenance Phase Following an Initial 4-weeks Acute Treatment Phase in Subjects With Symptoms Thought to be GERD Related.

Completed
Phase of Trial: Phase IV

Latest Information Update: 12 Jul 2011

At a glance

  • Drugs Aluminium hydroxide/magnesium hydroxide/simethicone; Esomeprazole
  • Indications Gastro-oesophageal reflux
  • Focus Therapeutic Use
  • Acronyms SYMPATHY
  • Sponsors AstraZeneca
  • Most Recent Events

    • 12 Jul 2011 New Source identified and integrated (European Clinical Trials Database)
    • 11 Jan 2008 Status changed from in progress to completed.
    • 02 Mar 2007 Status changed from recruiting to in progress.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top